These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 96470)
1. Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids. Anlezark G; Meldrum B Psychopharmacology (Berl); 1978 Apr; 57(1):57-62. PubMed ID: 96470 [TBL] [Abstract][Full Text] [Related]
2. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase. Horton RW; Meldrum BS Br J Pharmacol; 1973 Sep; 49(1):52-63. PubMed ID: 4207045 [TBL] [Abstract][Full Text] [Related]
3. Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio. Meldrum B; Anlezark G; Trimble M Eur J Pharmacol; 1975; 32(02):203-13. PubMed ID: 1149807 [TBL] [Abstract][Full Text] [Related]
4. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells. Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264 [TBL] [Abstract][Full Text] [Related]
5. [Modifications of the EEG and the photosensitivity of Papio papio under the effect of different derivatives of ergot]. Balzano E; Meldrum BS; Naquet R; Vuillon-Cacciuttolo G Rev Electroencephalogr Neurophysiol Clin; 1971; 1(2):219-30. PubMed ID: 5006269 [No Abstract] [Full Text] [Related]
6. Effects of opiate-like peptides, morphine, and naloxone in the photosensitive baboon, Papio papio. Meldrum BS; Menini C; Stutzmann JM; Naquet R Brain Res; 1979 Jul; 170(2):333-48. PubMed ID: 223724 [TBL] [Abstract][Full Text] [Related]
7. Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine. Horowski R Eur J Pharmacol; 1978 Sep; 51(2):157-66. PubMed ID: 699981 [No Abstract] [Full Text] [Related]
8. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. Holohean AM; White FJ; Appel JB Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388 [TBL] [Abstract][Full Text] [Related]
9. Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein. Foote AP; Harmon DL; Strickland JR; Bush LP; Klotz JL J Anim Sci; 2011 Sep; 89(9):2944-9. PubMed ID: 21512122 [TBL] [Abstract][Full Text] [Related]
10. Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats. Maeda-Hagiwara M; Watanabe K Eur J Pharmacol; 1982 Apr; 79(1-2):105-10. PubMed ID: 7084301 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the central effects of ergot alkaloids by means of electroencephalography. Longo VG; Loizzo A Pharmacology; 1978; 16 Suppl 1():189-92. PubMed ID: 643900 [TBL] [Abstract][Full Text] [Related]
12. Monoaminergic involvement in the behavioral effects of ergot derivatives. Appel JB; Cunningham KA; West KB Prog Clin Biol Res; 1985; 192():51-62. PubMed ID: 2867556 [TBL] [Abstract][Full Text] [Related]
13. The relationship between the anticonvulsant properties of SC-13504 and its plasma levels, measured by polarography, in baboons with photosensitive epilepsy. Meldrum BS; Smyth MR; Franklin-Smyth W; Clifford JM Psychopharmacology (Berl); 1976 Dec; 51(1):59-64. PubMed ID: 827776 [TBL] [Abstract][Full Text] [Related]